Literature DB >> 7062527

Hearing and middle ear function in osteogenesis imperfecta.

J R Shapiro, A Pikus, G Weiss, D W Rowe.   

Abstract

Fifty-five patients with osteogenesis imperfecta (OI) were studied to determine the extent to which the peripheral auditory mechanisms share in the connective tissue lesion. Ninety-two unaffected relatives and 43 control subjects were also studied. Subjects were divided into age groups younger than and older than 30 years. Hearing loss, most frequently sensorineural, occurred in 49% (younger than 30 years) and 94% (older than 30 years) of patients with OI. A sensorineural pattern of hearing loss, here considered characteristic of OI, was observed in 47% of OI subjects irrespective of age, in 42% of relatives, and 5% of controls. Middle ear analysis by tympanometry and acoustic reflex analysis indicates that, although some patients with OI have a still middle ear system similar to that seen in otosclerosis, the majority display absent acoustic reflexes and increased compliance of the middle ear with notched tympanograms suggestive of anomalous ossicular articulation. Similar findings in otherwise uninvolved relatives suggest a genetic basis for these defects.

Entities:  

Mesh:

Year:  1982        PMID: 7062527

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  12 in total

1.  Osteogenesis imperfecta and hearing loss: an analysis of patients attended at a benchmark treatment center in southern Brazil.

Authors:  Andressa Colares da Costa Otavio; Adriane Ribeiro Teixeira; Temis Maria Félix; Letícia Petersen Schimidt Rosito; Sady Selaimen da Costa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-31       Impact factor: 2.503

2.  Transgenic mouse model of the mild dominant form of osteogenesis imperfecta.

Authors:  J Bonadio; T L Saunders; E Tsai; S A Goldstein; J Morris-Wiman; L Brinkley; D F Dolan; R A Altschuler; J E Hawkins; J F Bateman
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

3.  Mutations linked to the pro alpha 2(I) collagen gene are responsible for several cases of osteogenesis imperfecta type I.

Authors:  G Wallis; P Beighton; C Boyd; C G Mathew
Journal:  J Med Genet       Date:  1986-10       Impact factor: 6.318

4.  Stapes surgery in osteogenesis imperfecta patients.

Authors:  R Dieler; J Müller; J Helms
Journal:  Eur Arch Otorhinolaryngol       Date:  1997       Impact factor: 2.503

5.  A cross-sectional multicenter study of osteogenesis imperfecta in North America - results from the linked clinical research centers.

Authors:  R M Patel; S C S Nagamani; D Cuthbertson; P M Campeau; J P Krischer; J R Shapiro; R D Steiner; P A Smith; M B Bober; P H Byers; M Pepin; M Durigova; F H Glorieux; F Rauch; B H Lee; T Hart; V R Sutton
Journal:  Clin Genet       Date:  2014-05-30       Impact factor: 4.438

6.  Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.

Authors:  P H Byers; J R Shapiro; D W Rowe; K E David; K A Holbrook
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

7.  Osteogenesis imperfecta of the temporal bone: CT and MR imaging in Van der Hoeve-de Kleyn syndrome.

Authors:  Hatem Alkadhi; Diana Rissmann; Spyros S Kollias
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

8.  Prolyl 3-hydroxylase-1 null mice exhibit hearing impairment and abnormal morphology of the middle ear bone joints.

Authors:  Elena Pokidysheva; Sara Tufa; Chris Bresee; John V Brigande; Hans Peter Bächinger
Journal:  Matrix Biol       Date:  2012-11-24       Impact factor: 11.583

9.  Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype.

Authors:  Freya K R Swinnen; Paul J Coucke; Anne M De Paepe; Sofie Symoens; Fransiska Malfait; Filomena V Gentile; Luca Sangiorgi; Patrizia D'Eufemia; Mauro Celli; Ton J T M Garretsen; Cor W R J Cremers; Ingeborg J M Dhooge; Els M R De Leenheer
Journal:  Orphanet J Rare Dis       Date:  2011-12-29       Impact factor: 4.123

10.  Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations.

Authors:  Joseph P Pillion; David Vernick; Jay Shapiro
Journal:  Genet Res Int       Date:  2011-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.